| 1 |
35246210 | Perfect match: mTOR inhibitors and tuberous sclerosis complex. | 2022 Mar 4 |
1 |
| 2 |
35359647 | Abnormal White Matter Microstructure in the Limbic System Is Associated With Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders. | 2022 |
1 |
| 3 |
35483522 | Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis. | 2022 Apr 25 |
1 |
| 4 |
35596872 | Genetic analysis of 18 families with tuberous sclerosis complex. | 2022 May 21 |
1 |
| 5 |
33307091 | Architecture of the Tuberous Sclerosis Protein Complex. | 2021 Jan 22 |
1 |
| 6 |
33398801 | Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes. | 2021 Apr |
2 |
| 7 |
33431351 | Genetic pathogenesis of the epileptogenic lesions in Tuberous Sclerosis Complex: Therapeutic targeting of the mTOR pathway. | 2021 Jan 8 |
1 |
| 8 |
33658088 | Everolimus treatment in a 3-month-old infant with tuberous sclerosis complex cardiac rhabdomyoma, severe left ventricular outflow tract obstruction, and hearing loss. | 2021 Aug |
2 |
| 9 |
33773987 | Long-Term Effects of Sirolimus on Human Skin TSC2-Null Fibroblast‒Like Cells. | 2021 Sep |
3 |
| 10 |
33860865 | Activated p53 in the anti-apoptotic milieu of tuberous sclerosis gene mutation induced diseases leads to cell death if thioredoxin reductase is inhibited. | 2021 Jun |
1 |
| 11 |
33891611 | Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer. | 2021 |
1 |
| 12 |
33902956 | Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria. | 2021 Oct |
8 |
| 13 |
33910008 | 4E-BP2-dependent translation in cerebellar Purkinje cells controls spatial memory but not autism-like behaviors. | 2021 Apr 27 |
1 |
| 14 |
33923449 | The Characterization of a Subependymal Giant Astrocytoma-Like Cell Line from Murine Astrocyte with mTORC1 Hyperactivation. | 2021 Apr 16 |
5 |
| 15 |
34079249 | Mesenchymal Stem Cells Attenuate Renal Fibrosis via Exosomes-Mediated Delivery of microRNA Let-7i-5p Antagomir. | 2021 |
1 |
| 16 |
34178631 | Normalization of Enzyme Expression and Activity Regulating Vitamin A Metabolism Increases RAR-Beta Expression and Reduces Cellular Migration and Proliferation in Diseases Caused by Tuberous Sclerosis Gene Mutations. | 2021 |
3 |
| 17 |
34295558 | TSC1/2 mutations-a unique type of mutation suitable for liver transplantation of Hepatocellular carcinoma. | 2021 Jun |
2 |
| 18 |
34301883 | Tsc1 regulates tight junction independent of mTORC1. | 2021 Jul 27 |
2 |
| 19 |
34349839 | Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine. | 2021 |
2 |
| 20 |
34544857 | Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells. | 2021 Sep 28 |
1 |
| 21 |
34778262 | The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back. | 2021 |
1 |
| 22 |
34806651 | Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice. | 2021 Nov 22 |
1 |
| 23 |
34853810 | RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1. | 2021 Dec 17 |
1 |
| 24 |
31834371 | The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas. | 2020 Jan 1 |
2 |
| 25 |
31869431 | Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformations. | 2020 Oct |
1 |
| 26 |
31921404 | TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling. | 2020 |
5 |
| 27 |
31958214 | Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex. | 2020 May |
5 |
| 28 |
32469097 | miR-196b-5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF-β signaling. | 2020 Jul |
1 |
| 29 |
32502382 | Structure of the TSC2 GAP Domain: Mechanistic Insight into Catalysis and Pathogenic Mutations. | 2020 Aug 4 |
1 |
| 30 |
32541317 | Medical treatment of advanced malignant perivascular epithelioid cell tumors. | 2020 Jul |
1 |
| 31 |
32579942 | Phenotypic Screen with TSC-Deficient Neurons Reveals Heat-Shock Machinery as a Druggable Pathway for mTORC1 and Reduced Cilia. | 2020 Jun 23 |
1 |
| 32 |
32739207 | Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis. | 2020 Sep |
2 |
| 33 |
32761379 | Genetics of tuberous sclerosis complex: an update. | 2020 Oct |
1 |
| 34 |
32765227 | The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC). | 2020 |
2 |
| 35 |
32927859 | Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells. | 2020 Sep 10 |
1 |
| 36 |
33193709 | Hamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning. | 2020 |
1 |
| 37 |
30728291 | Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1-dependent and -independent signaling pathways. | 2019 Feb 19 |
2 |
| 38 |
30904097 | Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies. | 2019 |
3 |
| 39 |
30988224 | [Tuberous Sclerosis Complex]. | 2019 Apr |
2 |
| 40 |
31665839 | [Rapamycin in the treatment of renal diseases associated with tuberous sclerosis complex]. | 2019 Nov 2 |
2 |
| 41 |
29339522 | Effect of beta-agonists on LAM progression and treatment. | 2018 Jan 30 |
2 |
| 42 |
29340326 | mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma. | 2018 Jan |
2 |
| 43 |
29478616 | Tuberous sclerosis complex. | 2018 |
2 |
| 44 |
29559472 | Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin. | 2018 Jun 1 |
3 |
| 45 |
29929111 | Calcification in cerebral parenchyma affects pharmacoresistant epilepsy in tuberous sclerosis. | 2018 Aug |
1 |
| 46 |
30087333 | TSC1 and DEPDC5 regulate HIV-1 latency through the mTOR signaling pathway. | 2018 Aug 8 |
1 |
| 47 |
30127391 | Genetically engineered human cortical spheroid models of tuberous sclerosis. | 2018 Oct |
2 |
| 48 |
30144504 | Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation. | 2018 Oct |
2 |
| 49 |
27225870 | Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer. | 2017 Feb |
1 |
| 50 |
27862655 | Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. | 2017 Jan |
5 |